After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Prime Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Prime Medicine Inc is $608.32M. A total of 4.07 million shares were traded on the day, compared to an average of 3.67M shares.
In the most recent transaction, GV 2021 GP, L.L.C. bought 1,500,000 shares of PRME for 3.30 per share on Aug 01 ’25. After the transaction, the 10% Owner now owns 3,262,440 company shares. In a previous transaction on Aug 01 ’25, NELSEN ROBERT bought 3,030,300 shares at 3.30 per share. PRME shares that Director owns now total 6,230,300.
Among the insiders who bought shares, ARCH Venture Partners XII, LLC acquired of 3,030,300 shares on Aug 01 ’25 at a per-share price of $3.30. This resulted in the 10% Owner holding 6,230,300 shares of PRME after the transaction. In another insider transaction, ARCH Venture Partners X, LLC bought 3,030,300 shares at $3.30 per share on Aug 01 ’25. Company shares held by the 10% Owner now total 6,230,300.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PRME has a high of $6.94 and a low of $1.11.
As of this writing, PRME has an earnings estimate of -$0.24 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.31 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PRME’s latest balance sheet shows that the firm has $269.62M in Cash & Short Term Investments as of fiscal 2021. There were $10.41M in debt and $57.98M in liabilities at the time. Its Book Value Per Share was $0.90, while its Total Shareholder’s Equity was $239.56M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRME is Buy with a score of 4.27.
